Related Experiment Videos
[Long-term effects of structum administration (according to data from multicenter trial)]
Terapevticheskii Arkhiv
|October 30, 2003
Summary
Structum provides a lasting clinical response for osteoarthritis (OA) patients, reducing exacerbations and improving quality of life. This drug effectively manages OA symptoms and positively impacts comorbid conditions.
Area of Science:
- Rheumatology
- Pharmacology
- Clinical Medicine
Background:
- Osteoarthritis (OA) is a degenerative joint disease affecting millions worldwide.
- Current treatments aim to manage pain and improve function, but long-term efficacy remains a challenge.
Purpose of the Study:
- To evaluate the duration of clinical response to Structum in patients with knee and hip osteoarthritis.
- To assess Structum's effects on the course of OA and concomitant diseases.
Main Methods:
- A 12-month, open-label, multicenter, randomized controlled trial involving 373 patients with knee and hip OA.
- Patients received Structum for 6 months, with assessments including pain, functional index, NSAID use, and exacerbations of OA and comorbid conditions.
Main Results:
- Structum demonstrated a sustained clinical response, with effects lasting an average of 4.1-4.6 months post-treatment.
- Therapy reduced exacerbations, hospitalizations, doctor visits, and NSAID requirements.
- A significant portion (40%) of patients experienced persistent effects 12 months after treatment, with improved outcomes in comorbid conditions.
Conclusions:
- Structum is a highly effective drug for osteoarthritis, offering prolonged symptom relief.
- It significantly reduces disease activity, healthcare utilization, and the need for NSAIDs.
- Structum also positively influences the course of certain concomitant diseases in OA patients.